Advocacy groups plead for end to two-year wait for Medicare coverage for disabled
Nov 14, 2008
Healthcare and disability advocacy groups have launched a campaign to end the two-year waiting period the disabled must endure before qualifying for Medicare.
Dementia signs, symptoms may be different for Latinos, researchers say
By
Alicia Lasek
May 27, 2021
Cultural practices and disease processes may explain why Latino adults with dementia experience faster functional decline and higher rates of depression and anxiety, investigators say.
Music intervention rejuvenates certain regions of the older brain: study
By
Alicia Lasek
Apr 24, 2023
Listening to music and playing a musical instrument may help to avert brain aging in the areas related to these actions, researchers in Switzerland and Germany have found.
COVID vaccines lost some effectiveness in delta surge, ongoing CDC study finds
By
Alicia Lasek
Aug 25, 2021
The three federally sanctioned COVID vaccines have lost a “moderate” amount of effectiveness against SARS-CoV-19 ever since the delta gene variant became the predominant U.S. strain, the agency reports.
First biosimilar approved by FDA to treat common eye degeneration in elders
By
Alicia Lasek
Sep 21, 2021
The Food and Drug Administration has approved a less expensive copy of the blockbuster drug Lucentis for treating age-related (wet) macular degeneration and several other eye conditions.
CVS Health ‘well positioned’ to serve LTC with future COVID-19 vaccine
By
Danielle Brown
Aug 06, 2020
Long-term care facilities that receive pharmacy services from CVS Health should have sufficient access to a COVID-19 vaccine, once one is ready, executives stated Wednesday morning.
FDA OKs third antibody COVID therapy; variants spur new pause on another
By
Alicia Lasek
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...
Epilepsy raises risk of developing Alzheimer’s, and vice-versa
By
Alicia Lasek
May 29, 2023
People with a common type of epilepsy have nearly four times the relative odds of receiving an Alzheimer’s diagnosis, a new study finds.
Long-term study links infections to 70 percent higher dementia risk
By
Alicia Lasek
Jan 10, 2023
A study with 32 years of followup has linked infections in hospitalized patients to future dementia onset. Urinary tract infections are among those with the strongest link.
HHS halts Eli Lilly’s single-drug COVID antibody treatment in U.S.; dual-drug alternative remains in...
By
Alicia Lasek
Mar 26, 2021
U.S. distribution of an infusion treatment using bamlanivimab only has been halted due to virus variant concerns, but an alternative antibody cocktail from the drugmaker can still be ordered, according...